» Authors » B N Hudspith

B N Hudspith

Explore the profile of B N Hudspith including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 355
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Elliott T, Hudspith B, Rayment N, Prescott N, Petrovska L, Hermon-Taylor J, et al.
J Gastroenterol Hepatol . 2015 Mar; 30(8):1265-74. PMID: 25809337
Background And Aim: Escherichia coli can be isolated from lamina propria macrophages in Crohn's disease (CD), and their intramacrophage persistence may provide a stimulus for inflammation. To further determine the...
2.
Parkes G, Rayment N, Hudspith B, Petrovska L, Lomer M, Brostoff J, et al.
Neurogastroenterol Motil . 2011 Nov; 24(1):31-9. PMID: 22070725
Background: There is increasing evidence to support a role for the gastrointestinal microbiota in the etiology of irritable bowel syndrome (IBS). Given the evidence of an inflammatory component to IBS,...
3.
Vandebriel R, Spiekstra S, Hudspith B, Meredith C, van Loveren H
Toxicology . 1999 Aug; 135(1):49-66. PMID: 10454224
Rat thymocytes and splenocytes were exposed in vitro to the model compounds Cyclosporin A (CsA), an immunosuppressive drug, and bis(tri-n-butyltin)oxide (TBTO), an immunotoxic environmental contaminant. The lymphocyte transformation test (LTT),...
4.
van Loveren H, Slob W, Vandebriel R, Hudspith B, Meredith C, Garssen J
Arch Toxicol Suppl . 1998 Jan; 20:285-92. PMID: 9442301
Bis(tri-n-butyltin)oxide (TBTO) has been shown to be immunotoxic in rodents, resulting in decreased resistance to infections. The no-effect level assessed by estimating effects on host resistance in rats has been...
5.
Miller K, Hudspith B, Meredith C
Environ Health Perspect . 1992 Jul; 97:85-9. PMID: 1396471
We have attempted to address the requirements necessary for alveolar macrophage accessory cell function. We have also examined the in vitro and in vivo factors that must be taken into...
6.
Hall T, Heckel C, Hudspith B, Brostoff J
Immunol Lett . 1990 May; 24(2):103-5. PMID: 2162327
Human T cell proliferative responses to concanavalin A (conA) were suppressed by approximately 50% by histamine (100 microM). In contrast, LiCl (1 or 3 mM) potentiated T cell responses by...
7.
Hucklebridge F, Hudspith B, Lydyard P, Brostoff J
Immunopharmacology . 1990 Mar; 19(2):87-91. PMID: 2161808
The opioid peptide methionine enkephalin was shown to stimulate human peripheral lymphocyte proliferation in vitro in the absence of mitogen. A study of the time course of stimulation revealed a...
8.
Murphy G, Dowd P, Hudspith B, Brostoff J, Greaves M
Photodermatol . 1989 Dec; 6(6):268-74. PMID: 2636982
Using an in vivo skin chamber method, we demonstrated increased release of interleukin-1 (IL-1)-like activity at the site of irradiation with 3 times the minimal erythema dose of ultraviolet B...
9.
Foley N, Coral A, Tung K, Hudspith B, James D, Johnson N
Thorax . 1989 Sep; 44(9):732-8. PMID: 2588210
Sixty seven patients with biopsy proven pulmonary sarcoidosis were prospectively studied to determine whether single point bronchoalveolar lavage cell counts were a useful indicator of functional outcome and whether repeated...
10.
Hucklebridge F, Hudspith B, Muhamed J, Lydyard P, Brostoff J
Brain Behav Immun . 1989 Jun; 3(2):183-9. PMID: 2551418
The influence of methionine-enkephalin (Met-Enk) on in vitro proliferation of human peripheral lymphocytes was investigated. Met-Enk, in the concentration range 10(-12) to 10(-4) M enhanced the proliferative response to suboptimal...